Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301248 | 1.00 | HMGCR (0.74) | HMGCRRXRA | |
| SCHEMBL247234 | 1.00 | HMGCR (0.74) | HMGCRRXRA | |
| SCHEMBL7481310 | 1.00 | HMGCR (0.74) | HMGCRRXRA | |
| SCHEMBL247233 | 1.00 | HMGCR (0.74) | HMGCRRXRA | |
| SCHEMBL10049194 | 0.89 | HMGCR (0.60) | HMGCRRXRA | |
| SCHEMBL13847591 | 0.89 | HMGCR (0.66) | HMGCR | |
| SCHEMBL13994086 | 0.88 | HMGCR (0.61) | HMGCR | |
| SCHEMBL13524825 | 0.88 | HMGCR (0.65) | HMGCR | |
| SCHEMBL13994087 | 0.88 | HMGCR (0.65) | HMGCR | |
| SCHEMBL14207592 | 0.88 | HMGCR (0.61) | HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115792001-A | Analysis method for determining pitavastatin tert-butyl ester related substances by using HPLC | 徐州万邦金桥制药有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-115792001-A | Analysis method for determining pitavastatin tert-butyl ester related substances by using HPLC | 徐州万邦金桥制药有限公司 | 2023-03-14 | — | — | CN | disclosed |
| US-20140140931-A1 | ANTIOXIDANT, NEUROPROTECTIVE AND ANTINEOPLASTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT ON AN AMPHIPHILIC SPACER OR AN AMPHIPHILIC POLYMER | CEDARS-SINAI MEDICAL CENTER (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140140931-A1 | ANTIOXIDANT, NEUROPROTECTIVE AND ANTINEOPLASTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT ON AN AMPHIPHILIC SPACER OR AN AMPHIPHILIC POLYMER | CEDARS-SINAI MEDICAL CENTER (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140105822-A1 | NANOSPHERES COMPRISING TOCOPHEROL, AN AMPHIPHILIC SPACER AND A THERAPEUTIC OR IMAGING AGENT | CEDARS-SINAI MEDICAL CENTER (US) | 2014-04-17 | — | — | US | disclosed |
| US-20140105822-A1 | NANOSPHERES COMPRISING TOCOPHEROL, AN AMPHIPHILIC SPACER AND A THERAPEUTIC OR IMAGING AGENT | CEDARS-SINAI MEDICAL CENTER (US) | 2014-04-17 | — | — | US | disclosed |
| WO-2013016696-A1 | ANTIOXIDANT, NEUROPROTECTIVE AND ANTINEOPLASTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT ON AN AMPHIPHILIC SPACER OR AN AMPHIPHILIC POLYMER | CEDARS-SINAI MEDICAL CENTER (US) | 2013-01-31 | — | — | WO | disclosed |
| WO-2011105649-A1 | NEW METHOD FOR MANUFACTURING PITAVASTATIN HEMICALCIUM USING NEW INTERMEDIATE | (주)메디켐코리아 (KR) | 2011-09-01 | — | — | WO | disclosed |
| US-7193086-B2 | Process for preparation of a quinolinecarbaldehyde | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-7193086-B2 | Process for preparation of a quinolinecarbaldehyde | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| EP-0747341-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE MEVALONOLACTONE COMPOUNDS | DAICEL CHEM (JP) | 2002-05-22 | — | — | EP | disclosed |
| EP-0747341-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE MEVALONOLACTONE COMPOUND | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140105822-A1 | NANOSPHERES COMPRISING TOCOPHEROL, AN AMPHIPHILIC SPACER AND A THERAPEUTIC OR IMAGING AGENT | TTPA, NFE2, GSTK1 | HMGCR 4/4885RXRA 406/4885 |
| US-20140140931-A1 | ANTIOXIDANT, NEUROPROTECTIVE AND ANTINEOPLASTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT ON AN AMPHIPHILIC SPACER OR AN AMPHIPHILIC POLYMER | NLN, CASP12, GPX4 | HMGCR 8/4885RXRA 1368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.